A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers

Adjuvant chemotherapy is considered the standard of care for patients with colorectal cancer after curative resection. Although current guidelines provide clear instructions for chemotherapy for stage II high-risk and stage III colorectal cancer, it is insufficient to individualize therapy. We analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yang, Lu, Su, Yu, Fudong, Liu, Xisheng, Sun, Huimin, Wang, Jingtao, Zhu, Xingwu, Lu, Huijun, Yue, Hao, Wang, Jing, Lin, Jun, Zhou, Chongzhi, Tang, Huamei, Peng, Zhihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109035/
https://www.ncbi.nlm.nih.gov/pubmed/27845412
http://dx.doi.org/10.1038/srep37240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109035/
https://www.ncbi.nlm.nih.gov/pubmed/27845412
http://dx.doi.org/10.1038/srep37240

Ejemplares similares